Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 9 Aug 21 EFFECT Notice of effectiveness
- 6 Aug 21 424B3 Prospectus supplement
- 4 Aug 21 S-4/A Registration of securities issued in business combination transactions (amended)
-
22 Jun 21 S-4 Registration of securities issued in business combination transactions
ENVB similar filings
- 4 Aug 21 Registration of securities issued in business combination transactions (amended)
- 22 Jun 21 Registration of securities issued in business combination transactions
- 10 Nov 20 Registration of securities issued in business combination transactions (amended)
- 9 Nov 20 Registration of securities issued in business combination transactions (amended)
- 22 Oct 20 Registration of securities issued in business combination transactions (amended)
Filing view
External links
Exhibit 99.3
The undersigned hereby consents to being named in this proxy statement/prospectus included in the Registration Statement on Form S-4 filed by Enveric Biosciences, Inc. (including any amendments to such Registration Statement) in connection with the Amalgamation Agreement, dated as of May 24, 2021, by and among Enveric Biosciences, Inc., 1306432 B.C. LTD., 1306436 B.C. LTD., and MagicMed Industries, Inc., as it may be amended from time to time, as a person who will become a director and to the filing of this consent as an exhibit to the Registration Statement.
Date: June 21, 2021 | /s/ Brad Thompson | ||
Name: | Brad Thompson |